Highlights of the Eighth International Conference on Carcinogenic/Mutagenic N-Substituted Aryl Compounds

Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis

Volumn 506-507, Issue , 2002, Pages 1-8

  Snyderwine, Elizabeth G ^a   Sinha, Rashmi ^a   Felton, James S ^b   Ferguson, Lynnette R ^c  

^a NATIONAL CANCER INSTITUTE   (United States)

^b LAWRENCE LIVERMORE NATIONAL LABORATORY   (United States)

^c UNIVERSITY OF AUCKLAND   (New Zealand)

Author keywords

Aromatic amines; Biomonitoring; Carcinogenesis; DNA adducts; Epidemiology; Heterocyclic amines; Human exposure and risk; Metabolism; Molecular alterations; Mutagenesis

Indexed keywords

AROMATIC AMINE; CYTOCHROME P450 1A2; HETEROCYCLIC AMINE; MUTAGENIC AGENT; POLYCYCLIC AROMATIC HYDROCARBON DERIVATIVE;

CANCER RESEARCH; CARCINOGENESIS; CARCINOGENIC ACTIVITY; CONFERENCE PAPER; HUMAN; MEDICAL RESEARCH; MUTATION; NONHUMAN; PRIORITY JOURNAL; PROSPECTIVE STUDY; PUBLICATION; SYMPOSIUM;

AMINOBIPHENYL COMPOUNDS; CARCINOGENS; CARCINOGENS, ENVIRONMENTAL; DIET; DNA ADDUCTS; DNA DAMAGE; DNA, NEOPLASM; ENVIRONMENTAL MONITORING; HUMANS; MUTAGENS; NEOPLASMS; RISK FACTORS;

EID: 0037201489     PISSN: 00275107     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0027-5107(02)00146-X     Document Type: Conference Paper

References (65)

1. J.H. Weisburger, Comments on the history and importance of aromatic and heterocyclic amines in public health, Mutat. Res. 506-507 (2002) 9-20.
2. R.C. Garner, C.N. Martin, D.B. Clayson, Carcinogenic aromatic amines and related compounds, in: C.E. Searle (Ed.), Chemical Carcinogens, Vol. 1, ACS Monograph 182, American Chemical Society, Washington, DC, 1984, pp. 175-213.
3. M.C. Yu, P.L. Skipper, S.R. Tannenbaum, K.K. Chan, R.K. Ross, Arylamine exposures and bladder cancer risk, Mutat. Res. 506-507 (2002) 21-28.
4. Marcus P.M., Hayes R.B., Vineis P., Garcia-Closas M., Caporaso N.E., Autrup H., Branch R.A., Brockmoller J., Ishizaki T., Karakaya A.E., Ladero J.M., Mommsen S., Okkels H., Romkes M., Roots I., Rothman N. Cigarette smoking, N-acetyltransferase 2 acetylation status, and bladder cancer risk: a case-series meta-analysis of a gene-environment interaction. Cancer Epidemiol. Biomarkers Prev. 9:2000;461-467.
5. T.V. Zenser, V.M. Lakshmi, F.F. Hsu, B.B. Davis, Metabolism of N-acetylbenzidine and initiation of bladder cancer, Mutat. Res. 506-507 (2002) 29-40.
6. Talaska G., al-Juburi A.Z., Kadlubar F.F. Smoking related carcinogen-DNA adducts in biopsy samples of human urinary bladder: identification of N-(deoxyguanosin-8-yl)-4-aminobiphenyl as a major adduct. Proc. Natl. Acad. Sci. U.S.A. 88:1991;5350-5354.
7. M.M. Marques, G. Gamboa da Costa, L.R. Blankenship, S.J. Culp, F.A. Beland, The effect of deuterium and fluorine substitution upon the mutagenicity of N-hydroxy-2,6-dimethylaniline, Mutat. Res. 506-507 (2002) 41-48.
8. Castelao J.E., Yuan J.M., Skipper P.L., Tannenbaum S.R., Gago-Dominguez M., Crowder J.S., Ross R.K., Yu M.C. Gender and smoking-related bladder cancer risk. J. Natl. Cancer Inst. 93:2001;538-545.
9. Y. Totsuka, H. Kataoka, T. Enya-Takamura, T. Sugimura, K. Wakabayashi, In vitro and in vivo formation of aminophenylnorharman from norharman and aniline, Mutat. Res. 506-507 (2002) 49-54.
10. S.J. Culp, F.A. Beland, R.H. Heflich, R.W. Benson, L.R. Blankenship, P.J. Webb, P.W. Mellick, R.W. Trotter, S.D. Shelton, K.J. Greenlees, M.G. Manjanatha, Mutagenicity and carcinogenicity in relation to DNA adduct formation in rats fed leucomalachite green, Mutat. Res. 506-507 (2002) 55-63.
11. D.W. Hein, Molecular genetics and function of NAT1 and NAT2: Role in aromatic amine metabolism and carcinogenesis, Mutat. Res.
12. Hein D.W., Doll M.A., Fretland A.J., Leff M.A., Webb S.J., Xiao G.H., Davanaboyina U.-S., Nangju N.A., Feng Y. Molecular genetics and epidemiology of the NAT1 and NAT2 acetylation polymorphisms. Cancer Epidemiol. Biomarkers Prev. 9:2000;29-42.
13. Schut H.A.J., Snyderwine E.G. DNA adducts of heterocyclic amine food mutagens: implications for mutagenesis and carcinogenesis. Carcinogenesis. 20:1999;353-368.
14. Sugimura T. Mutagens, carcinogens and tumor promoters in our daily food. Cancer. 49:1982;1970-1984.
15. Burnouf D.Y., Fuchs R.P. The early detection of frameshift mutations induced by a food-borne carcinogen in rats: a new tool for molecular epidemiology. Mutat. Res. 462:2000;281-291.
16. Stuart G.R., Thorleifson E., Okochi E., de Boer J.G., Ushijima T., Nagao M., Glickman B.W. Interpretation of mutational spectra from different genes: analyses of PhIP-induced mutational specificity in the lacI and cII transgenes from colon of Big Blue rats. Mutat. Res. 452:2000;101-121.
17. Colvin M.E., Hatch F.T., Felton J.S. Chemical and biological factors affecting mutagen potency. Mutat. Res. 400:1998;479-492.
18. J.C. Sasaki, R.S. Fellers, M.E. Colvin, Metabolic oxidation of carcinogenic arylamines by P450 monooxygenases: theoretical support for the one electron transfer mechanism, Mutat. Res. 506-507 (2002) 79-89.
19. Pfau W., Martin F.L., Cole K.J., Venitt S., Phillips D.H., Grover P.L., Marquardt H. Heterocyclic aromatic amines induce DNA strand breaks and cell transformation. Carcinogenesis. 20:1999;545-551.
20. Wu R.W., Panteleakos F.N., Kadkhodayan S., Bolton-Grob R., McManus M.E., Felton J.S. Genetically modified Chinese hamster ovary cells for investigating sulfotransferase-mediated cytotoxicity and mutation by 2-amino-1-methy-6-phenylimidazo[4,5-b]pyridine. Environ. Mol. Mutagen. 35:2000;57-65.
21. Leong-Morgenthaler P.M., Duc R., Morgenthaler S. Comparison of the mutagenic responses of mismatch repair-proficient (TK6) and mismatch repair-deficient (MT1) human lymphoblast cells to the food-borne carcinogen PhIP. Environ. Mol. Mutagen. 38:2001;323-328.
22. N.J. Gooderham, H. Zhu, S. Lauber, A. Boyce, S. Creton, Molecular and genetic toxicology of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP), Mutat. Res. 506-507 (2002) 91-99.
23. Layton D.W., Bogen K.T., Knize M.G., Hatch F.T., Johnson V.M., Felton J.S. Cancer risk of heterocyclic amines in cooked foods: an analysis and implications for research. Carcinogenesis. 16:1995;39-52.
24. Shan L., Rouhani S.A., Schut H.A.J., Snyderwine E.G. 2-Amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) modulates lactogenic hormone-mediated differentiation and gene expression in HC11 mouse mammary epithelial cells. Cell Growth Differ. 12:2001;649-656.
25. Nagao M. A new approach to risk estimation of food-borne carcinogens-heterocyclic amines-based on molecular information. Mutat. Res. 431:1999;3-12.
26. Yu M., Jones M.L., Gong M., Sinha R., Schut H.A.J., Snyderwine E.G. Mutagenicity of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) in the mammary gland of Big Blue rats on high- and low-fat diets. Carcinogenesis. 23:2002;877-884.
27. E. Okochi, N. Watanabe, T. Sugimura, T. Ushijima, Single nucleotide instability: A wide involvement in human and rat mammary carcinogenesis? Mutat. Res. 506-507 (2002) 101-111.
28. Watanabe N., Okochi E., Hirayama Y., Shimada Y., Yanagihara K., Yoshida M.C., Takahashi S., Mochizuki M., Sugimura T., Nagao M., Ushijima T. Single nucleotide instability without microsatellite instability in rat mammary carcinomas. Cancer Res. 61:2001;2632-2640.
29. A.T. Christian, E.G. Snyderwine, J.D. Tucker, Comparative genomic hybridization analysis of PhIP-induced mammary carcinomas in rats reveals a cytogenetic signature, Mutat. Res.
30. deltaNB-cat mutant mice to treatment with tea, sulindac, and 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP), Mutat. Res.
31. Dashwood R.H., Suzui M., Nakagama H., Sugimura T., Nagao M. High frequency of beta-catenin (ctnnb1) mutations in the colon tumors induced by two heterocyclic amines in the F344 rat. Cancer Res. 58:1998;1127-1129.
32. Blum C.A., Xu M., Orner G.A., Fong A.T., Bailey G.S., Stoner G.D., Horio D.T., Dashwood R.H. beta-Catenin mutation in rat colon tumors initiated by 1,2-dimethylhydrazine and 2-amino-3-methylimidazo[4,5-f]quinoline, and the effect of post-initiation treatment with chlorophyllin and indole-3-carbinol. Carcinogenesis. 22:2001;315-320.
33. Andreassen A., Mollersen L., Vikse R., Steffensen I.L., Mikalsen A., Paulsen J.E., Alexander J. One dose of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) or 2-amino-3-methylimidazo[4,5-f]quinoline (IQ) induces tumours in min/+ mice by truncation mutations or LOH in the APC gene. Mutat Res. 517:2002;157-166.
34. T. Shirai, K. Kato, M. Futakuchi, S. Takahashi, S. Suzuki, K. Imaida, M. Asamoto, Organ differences in the enhancing potential of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine in the prostate, colon and pancreas, Mutat. Res. 506-507 (2002) 129-136.
35. H. Nakagama, M. Ochiai, T. Ubagai, R. Tajima, K. Fugiwara, T. Sugimura, M. Nagao, A rat colon cancer model induced by 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine, PhIP, Mutat. Res. 506-507 (2002) 137-144.
36. E.G. Snyderwine, M. Venugopal, M. Yu, Mammary gland carcinogenesis by food-derived heterocyclic amines and studies on the mechanisms of carcinogenesis of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP), Mutat. Res. 506-507 (2002) 145-152.
37. Shirai T., Takahashi S., Cui L., Futakuchi M., Kato K., Tamano S., Imaida K. Experimental prostate carcinogenesis - rodent models. Mutat. Res. 462:2000;219-226.
38. Hasegawa R., Sano M., Tamano S., Imaida K., Shirai T., Nagao M., Sugimura T., Ito N. Dose-dependence of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) carcinogenicity in rats. Carcinogenesis. 14:1993;2553-2557.
39. Nagao M., Ushijima T., Watanabe N., Okochi E., Ochiai M., Nakagama H., Sugimura T. Studies on mammary carcinogenesis induced by a heterocyclic amine, 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine, in mice and rats. Environ. Mol. Mutagen. 39:2002;158-164.
40. Ito N., Hasegawa R., Sano M., Tamano S., Esumi H., Takayama S., Sugimura T. A new colon and mammary carcinogen in cooked food, 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP). Carcinogenesis. 12:1991;1503-1506.
41. Ghoshal A., Snyderwine E.G. Excretion of food-derived heterocyclic amine carcinogens into breast milk of lactating rats and formation of DNA adducts in the newborn. Carcinogenesis. 14:1993;2199-2203.
42. Snyderwine E.G. Some perspectives on the nutritional aspects of breast cancer research. Cancer. 74(Suppl.):1994;1070-1077.
43. M. Knize, K.S. Kulp, C.P. Salmon, G.A. Keating, J.S. Felton, Factors affecting human heterocyclic amine intake and the metabolism of PhIP, Mutat. Res. 506-507 (2002) 153-162.
44. P.T. Strickland, Z. Qian, M.D. Friesen, N. Rothman, R. Sinha, Metabolites of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) in human urine after consumption of charbroiled or fried beef, Mutat. Res. 506-507 (2002) 163-173.
45. Kulp K.S., Knize M.G., Malfatti M.A., Salmon C.P., Felton J.S. Identification of urine metabolites of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine following consumption of a single cooked chicken meal in humans. Carcinogenesis. 11:2000;2065-2072.
46. Stillwell W.G., Sinha R., Tannenbaum S.R. Excretion of the N(2)-glucuronide conjugate of 2-hydroxyamino-1-methyl-6-phenylimidazo[4,5-b]pyridine in relationship to CYP1A2 and NAT2 activity levels in humans. Carcinogenesis. 23:2002;831-838.
47. DeBruin L.S., Martos P.A., Josephy P.D. Detection of 2-amino-l-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) in the milk of healthy women. Chem. Res. Toxicol. 14:2001;1523-1528.
48. S. Nowell, B. Coles, R. Sinha, S. MacLeod, L. Ratnasinghe, C. Stotts, F.F. Kadlubar, C.B. Ambrosone, N.P. Lang, Analysis of total meat intake and exposure to individual heterocyclic amines in case-control study of colorectal cancer: contribution of metabolic variation to risk, Mutat. Res. 506-507 (2002) 175-185.
49. Carlini E.J., Rafiogianis R.B., Wood T.C., Jin F., Zheng W., Rebbeck T.R., Weinshilboum R.M. Sulfation pharmacogenetics: SULT1A1 and SULT1A2 allele frequencies in Caucasian, Chinese and African-American subjects. Pharmacogenetics. 11:2001;57-68.
50. R.T. Turesky, F.P. Guengerich, A. Guillouzo, S. Langouet, Metabolism of heterocyclic aromatic amines by human hepatocytes and cytochrome P450IA2, Mutat. Res. 506-507 (2002) 187-195.
51. Turteltaub K.W., Dingley K.H., Curtis K.D., Malfatti M.A., Turesky R.J., Garner R.C., Felton J.S., Lang N.P. Macromolecular adduct formation and metabolism of heterocyclic amines in humans and rodents at low doses. Cancer Lett. 143:1999;149-155.
52. Dingley K.H., Curtis K.D., Nowell S., Felton J.S., Lang N.P., Turteltaub K.W. DNA and protein adduct formation in the colon and blood of humans alter exposure to a dietary-relevant dose of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine. Cancer Epidemiol. Biomarkers Prev. 8:1999;507-512.
53. Lightfoot T.J., Coxhead J.M., Cupid B.C., Nicholson S., Garner R.C. Analysis of DNA adducts by accelerator mass spectrometry in human breast tissue alter administration of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine and benzo[a]pyrene. Mutat. Res. 472:2000;119-127.
54. Thompson P.A., DeMarini D.M., Kadlubar F.F., McClure G.Y., Brooks L.R., Green B.L., Fares M.Y., Stone A., Josephy P.D., Ambrosone C.B. Evidence for the presence of mutagenic arylamines in human breast milk and DNA adducts in exfoliated breast ductal epithelial cells. Environ. Mol. Mutagen. 39:2002;134-142.
55. 14C -acetic anhydride and accelerator mass spectrometry Chem. Biol. Interact. 126:2000;171-183.
56. R. Sinha, An epidemiologic approach to studying heterocyclic amines, Mutat. Res. 506-507 (2002) 197-204.
57. Sinha R., Chow W.H., Kulldorff M., Denobile J., Butler J., Garcia-Closas M., Weil R., Hoover R.N., Rothman N. Well-done grilled red meat increases the risk of colorectal adenomas. Cancer Res. 59:1999;4320-4324.
58. L. Le Marchand, J.H. Hankin, L.M. Pierce, R. Sinha, P.V. Nerurkar, A.A. Franke, L.R. Wilkens, L.N. Kolonel, T. Donlon, A. Seifried, L.J. Custer, A. Lum-Jones, W. Chang, Well-done red meat, metabolic phenotypes and colorectal cancer in Hawaii, Mutat. Res. 506-507 (2002) 205-214.
59. Sinha R., Gustafson D.R., Kulldorff M., Wen W.Q., Cerhan J.R., Zheng W. 2-Amino-1-methyl-6-phenylimidazo[4,5-b]pyridine, a carcinogen in high temperature cooked meat, and breast cancer. J. Natl. Cancer Inst. 92:2000;1352-1354.
60. Norrish A.E., Ferguson L.R., Knize M.G., Felton J.S., Sharpe S.J., Jackson R.T. Heterocyclic amine content of cooked meat and risk of prostate cancer. J. Natl. Cancer Inst. 91:1999;2038-2044.
61. L.R. Ferguson, Meat consumption, cancer risk and population groups within New Zealand, Mutat. Res. 506-507 (2002) 215-224.
62. Sinha R., Kulldorff M., Curtin J., Brown C.C., Alavanja M.C.R., Swanson C.A. Fried, well-done red meat and risk of lung cancer in women (United States). Cancer Causes Control. 9:1998;621-630.
63. K.E. Anderson, R. Sinha, M. Kulldorff, M. Gross, N.P. Lang, C. Barber, L. Harnack, B. DiMagno, R. Bliss, F.F. Kadlubar, Meat intake and cooking techniques: associations with pancreatic cancer, Mutat. Res. 506-507 (2002) 225-231.
64. M. Kobayashi, T. Hanaoka, S. Nishioka, H. Kataoka, S. Tsugane, Estimation of dietary heterocyclic amine intakes in a large-scale population-based prospective study in Japan, Mutat. Res. 506-507 (2002) 233-241.
65. E. Matos, A. Brandani, Review on meat consumption and cancer in South America, Mutat. Res. 506-507 (2002) 243-249.